The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bidmc.org

Founded Year

1996

Stage

Merger | Merged

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is an academic medical center. Some of the centers departments include: Cancer Center, Pharmacy, Radiology, Surgery, Radiation Oncology, Neurology, and Dermatology.

Beth Israel Deaconess Medical Center Headquarter Location

330 Brookline Avenue

Boston, Massachusetts, 02215,

United States

617-667-7000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Beth Israel Deaconess Medical Center Patents

Beth Israel Deaconess Medical Center has filed 475 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Transcription factors
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/23/2019

5/17/2022

Beta blockers, Calcium channel blockers, Prodrugs, Carboxamides, ACE inhibitors

Grant

Application Date

7/23/2019

Grant Date

5/17/2022

Title

Related Topics

Beta blockers, Calcium channel blockers, Prodrugs, Carboxamides, ACE inhibitors

Status

Grant

Latest Beth Israel Deaconess Medical Center News

8 studies by former Beth Israel physician retracted over oversight issues

Apr 4, 2022

Kelly Gooch - Large Eight studies or abstracts led by a former Harvard professor and Beth Israel Deaconess Medical Center ophthalmologist were retracted by three medical journals over issues with critical oversight approvals for the research,  The Boston Globe reported April 3. Jorge Arroyo, MD, led the research. Retracted studies include research published in Wiley Online Library in June, as well as a study published in March 2021 in Translational Vision Science & Technology, according to the Globe. Also retracted were six summaries of clinical trials led by Dr. Arroyo and published in Investigative Ophthalmology & Visual Science journals. Reasoning for the retractions involved conducting one study in a different way from hospital-approved protocol; failing to obtain institutional approval for another study; and for abstracts either failing to secure approvals or adhere to approved procedures, the Globe reported. According to the  University of Rhode Island , federal regulations require that research involving humans be reviewed by an institutional review board. Dr. Arroyo is no longer on the faculty at Boston-based Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. Previously, he worked as director of retina service at the hospital from January 2004-December 2021, according to his LinkedIn  page . The page shows Dr. Arroyo currently works as a vitreoretinal surgeon for Boston Vision. Dr. Arroyo told the Globe he preferred not to talk about the retractions or the timing of his departure from Beth Israel Deaconess. "It's a complicated issue, and all I can say is people make mistakes," he told the newspaper, adding later in a statement that the retractions were "part of my cooperation with the Beth Israel Deaconess Medical Center during their review of this matter." Terri Janos, a hospital spokesperson, told Becker's the hospital is unable to discuss personnel issues but did provide a statement. "We are fully committed to upholding the highest research standards and to rigorously maintaining the integrity of our research," the statement said. "Any concerns brought to our attention are thoroughly reviewed in accordance with institutional policies and applicable regulations." Read the full Globe report  here .

  • When was Beth Israel Deaconess Medical Center founded?

    Beth Israel Deaconess Medical Center was founded in 1996.

  • Where is Beth Israel Deaconess Medical Center's headquarters?

    Beth Israel Deaconess Medical Center's headquarters is located at 330 Brookline Avenue, Boston.

  • What is Beth Israel Deaconess Medical Center's latest funding round?

    Beth Israel Deaconess Medical Center's latest funding round is Merger.

  • Who are the investors of Beth Israel Deaconess Medical Center?

    Investors of Beth Israel Deaconess Medical Center include Concentra, Dignity Health, Salix Ventures, Three Arch Partners, AIG Investments and 8 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.